The Clinical Dermatology MSc is an advanced study programme aimed at medical graduates wishing to specialise in the field of dermatology. You will gain advanced practical training in laboratory sciences relevant to skin disease, and enhance your skills and knowledge of the scientific basis of clinical dermatology. The study pathway also includes a critical evaluation of dermatological literature on a specialist subject.
The Clinical Dermatology MSc will provide you with the opportunities to develop and demonstrate a comprehensive knowledge and understanding of dermatological diseases.
Located within the St John's Institute of Dermatology, a specialised clinical, teaching and research institute based in Guy's and St Thomas' hospitals, the course has full access to academic facilities including a lecture room, study areas and teaching laboratory.
The study pathway is made up of a combination of clinical sessions, lectures, seminars and conferences by members of the faculty as well as invited prominent speakers, creating a demanding and stimulating learning experience.
You will study three 60-credit modules throughout the year including theoretical dermatology and clinical dermatology, plus a research project with a dissertation related to clinical dermatology to complete the 180-credit advanced course.
You will be taught through a combination of lectures, seminars and self study.
The primary method of assessment for this course is a combination of essay writing, course work in the form of a clinical Poweroint presentation, pathology slide reading at the microscope, clinical and theoretical OSCEs and a written dissertation and its defence.
This course is primarily taught at the King’s College London Guy’s and St Thomas’ campuses.
King’s College is regulated by the Higher Education Funding Council for England.
Our graduates have found employment in senior hospital posts and private practice overseas. Some of our graduates have pursued further higher qualifications and Foundation Programmes in the UK.
Our MRes Experimental Medicine (Dermatology) programme will give nurses, doctors, clinical researchers and research programme managers the skills needed to work in early phase clinical studies.
You will learn how to master experimental medicine with a focus on dermatology through a combination of traditional teaching and hands-on learning, through spending a year working closely with the Experimental Medicine Dermatology Team of the Biomedical Research Centre while also taking four structured taught units.
The taught units will see you learn the details of designing and delivering Phase 1 clinical studies, understanding the pre-clinical data required before a clinical programme can commence, and how to optimise early clinical studies to provide evidence for progressing a promising drug or intervention into Phase II/III clinical testing.
Alongside the taught elements, you will have a named supervisor and be exposed to tasks required in the setup, delivery, interpretation and audit of a clinical study.
Nursing and physician students may participate in patient care, including new and follow-on patient clinics, treatment and care-giving episodes with patients.
For non-registered clinical researchers and research programme managers, no direct patient contact is envisaged and you may participate in clinical trial setup, protocol amendments, database setup, data entry, costing and billing for clinical research.
You will be able to choose two aspects of your direct clinical trial research experience to write up for your two research projects in a dissertation format. This will give you the skills and knowledge required to critically report medical, scientific and clinically related sciences for peer review.
The primary purpose of the MRes in Experimental Medicine (Dermatology) is to provide you with the opportunity to work within a premier Biomedical Research Centre and, through a mix of taught and experiential learning, master the discipline of experimental medicine related to dermatology.
Extensive practical experience
You will spend most of your time gaining hands-on experience through completion of two research projects working closely with the Experimental Medicine Dermatology Team of the Manchester Biomedical Research Centre.
Taught by experts in Experimental Medicine within dedicated research and clinical trials facilities
You will also have opportunities to interact with and learn from experimental medicine researchers across a range of different fields within the Manchester Biomedical Research Centre and the Manchester Clinical Research Facility and thereby broaden your knowledge and experience of experimental medicine.
Our MSc Skin Ageing and Aesthetic Medicine course is specifically designed for qualified medical or dental practitioners who want to develop their knowledge of cosmetic medicine.
This is an intensive part-time course encompassing the science of skin ageing and aesthetics, the application of evidence-based practice, and the clinical assessment and management of patients presenting with aesthetic problems.
You will be encouraged to develop a translational, professional approach to learning throughout the course, which can be applied to your future learning.
In addition, supervision and training is provided by national and international leaders (PDF, 1.9MB) working in aesthetic research, regulation and clinical practice. The combination of research and clinical expertise in skin ageing and aesthetic medicine at The University of Manchester and Salford Royal NHS Foundation Trust will enable you to learn from an interdisciplinary faculty of dermatologists, plastic surgeons, oculoplastic surgeons, maxillo-facial surgeons, dentists and psychologists, in addition to skin ageing and wound research basic scientists.
The theoretical component of this course is delivered online. You are also required to attend an induction day at the main University campus in September 2018 and two residential weeks in January 2019 and November 2019 (exact dates to be confirmed).
We aim to develop professionals with the ability to apply scientific principles and the latest evidence base to the practice of skin ageing and aesthetic medicine.
You will develop clinical knowledge, specialist practical skills and critical awareness of non-surgical procedures, supported by leading experts in the field.
On completion of the course, you will be able to demonstrate a number of competencies and have enhanced knowledge and skills including:
This course has been recognised as a gold standard for education in aesthetic practice by Health Education England. It aligns directly with the outcomes of the UK Department of Health review on cosmetic practice and General Medical Council guidance in this area.
You will receive one-to-one tutor support throughout the course, with small group sessions and bedside training with volunteer models during the clinical sessions.
Learn from the experts
Staff on the course include members of the Centre for Dermatology , which is recognised as a global leader in basic science, translational and clinical research in skin health and disease and is 1st in the UK for dermatology research (RAND analysis).
This course has been designed using established educational theory and practices to enhance student experience and learning.
The University of Manchester virtual learning environment (Blackboard) guides participants through unit content, assessment submission and programme information.
Our units use blended teaching methods aligned with learning outcomes and assessment. The course contains e-learning case work, small group work, interactive forums, clinical debriefs, and practical sessions with volunteer models. You will be taught in small ratios (1:5) to maximise opportunities for clinical learning.
We hold two face-to-face 5-day residential sessions during the first 24 months of course, one in each of the two first years. Both of these will be scheduled in the first semester and dates should be circulated in September. Attendance at the residential sessions is compulsory for all students.
An initial Induction Day is held in Manchester at the start of Year 1 and 3 to familiarise participants with the online e-learning software and library resources. Attendance at the Induction Day is also compulsory for all students.
This course is led by an experienced team of dermatology experts (PDF, 1.9MB).
You will be required to pass group and written assignments for each unit. Those with a highly practical element will also include assessments of procedural skills.
The master's element of the course will be assessed through a written dissertation (12,000 words).
Our MSc consists of seven units over three years. Completing the first six units leads to a PGDip in Skin Ageing and Aesthetic Medicine, with a focus on the more clinical aspects of the field. The seventh unit offers students the opportunity to undertake an individual piece of research.
Year 3 (MSc)
All units are compulsory.
With the gap in training highlighted by the UK government review of cosmetic practice, it is likely all aesthetic practitioners in the UK will need to provide evidence of their credentials.
Our course does not provide a professional competence framework, but goes beyond this to offer integrated knowledge and the application of critical skills enveloped within high quality professional behaviours.
Graduates of this course will acquire a comprehensive knowledge base that can be applied to their future or current clinical practice.
Advanced Practice is a part-time programme for experienced healthcare practitioners in hospital and community settings. The programme builds on your existing skills and experience to enable you to lead and support the development and delivery of evidence-based practice. Module outcomes are mapped against the Knowledge and Skills Framework so NHS employees can identify learning to support career progression.
This programme is suitable for practitioners, educators and managers from many healthcare disciplines who are developing autonomous practice, supporting educational and practice development or exercising clinical leadership. Practitioners may choose to follow a generic pathway or choose from a number of clinical specialities. Applicants are generally expected to be working within the chosen specialist field.
The programme is relevant for qualified healthcare practitioners in the following areas or roles: Cancer Nursing, Cardiac Care, Child Healthcare, Critical Care, Dermatology, Diabetes Care, District Nursing, Leadership, Midwifery, Palliative Care, Primary Care Nurse Practitioner/Community Matron/Case Manager, Women's Health Care.
Modules will only run if there are sufficient numbers of students enrolled and the minimum number is 12.
This programme is intended for experienced healthcare practitioners who are seeking to advance their practice, enhance their knowledge of research and evidence-based healthcare, and develop their roles.
This programme is part-time with taught sessions comprising a mixture of one day per week attendance and study blocks. Students select from modules rated at 15 or 30 credits. Students may elect to undertake one or more practice portfolios where practice accounts are used to demonstrate specialist or advanced practice.
Students are assessed through a combination of coursework and examinations. This can include written assignments such as essays, portfolios and dissertations. In addition, some modules will require students to undertake a presentation as part of the module assessment. A small number of modules are assessed by an exam, such as an unseen written examination or a computer-based assessment.
All students will also have to complete a clinical-based competency assessment as part of the MSc/PGDip/PGCert Advanced Practice pathway. This assessment is a clinical hurdle with 0 credits and is undertaken in the student’s workplace with an assessor.
Possible options after taking this programme include advanced practice roles such as nurse consultant, specialist practice roles, education, research and audit.
This online programme will give you a comprehensive understanding of the processes, investigation procedures and treatment options for common diseases you encounter in general medical practice.
The programme is mostly for early postgraduate doctors. It complements the learning you need to achieve membership of the Royal College of Physicians and it may also be suitable for doctors in other specialties, or nurse consultants and other paramedical specialists with extensive clinical experience.
We cover basic physiology, pathophysiology, therapy and clinical management, as well as clinical skills, generic skills (including writing and research methods) law, ethics and prescribing ability.
Problem-based learning through clinical case scenarios will be used to enhance knowledge and clinical decision-making. We use a variety of e-learning resources and platforms, including a virtual classroom with online tutorials and lectures, online interactive resources and virtual patients.
Our online learning technology is fully interactive, award-winning and enables you to communicate with our highly qualified teaching staff from the comfort of your own home or workplace. Students not only have access to Edinburgh’s excellent resources, but also become part of a supportive online community, bringing together students and tutors from around the world.
This programme is made up of compulsory and optional courses.
Further programme information
This programme is designed to help medical professionals gain the next step in their medical career, with a highly regarded qualification and first-rate expertise.
We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.